Free Trial

Gevo (NASDAQ:GEVO) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Gevo logo with Energy background
Image from MarketBeat Media, LLC.

Key Points

  • Gevo beat expectations, reporting EPS of ($0.02) vs. consensus ($0.03) and revenue of $45.35 million vs. $43.52 million, though the company remains unprofitable with a net margin of -37.33% and ROE of -9.49%.
  • The stock traded down about 1% to $1.89 on heavy volume (5.09M vs. avg. 2.59M), with a market cap of ~$458M and a 12-month range of $0.92–$2.95.
  • CFO sold shares (73,284 shares, a 21.27% reduction in his holdings) amid recent insider selling, and analysts remain mixed—consensus rating "Hold" with an average target of $6.42.
  • MarketBeat previews the top five stocks to own by May 1st.

Gevo (NASDAQ:GEVO - Get Free Report) posted its earnings results on Thursday. The energy company reported ($0.02) EPS for the quarter, beating analysts' consensus estimates of ($0.03) by $0.01, FiscalAI reports. The firm had revenue of $45.35 million during the quarter, compared to the consensus estimate of $43.52 million. Gevo had a negative return on equity of 9.49% and a negative net margin of 37.33%.

Gevo Trading Down 1.0%

Shares of Gevo stock traded down $0.02 during trading on Thursday, hitting $1.89. The stock had a trading volume of 5,093,201 shares, compared to its average volume of 2,594,243. Gevo has a 12 month low of $0.92 and a 12 month high of $2.95. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.91 and a quick ratio of 1.60. The firm's fifty day simple moving average is $1.95 and its 200-day simple moving average is $2.03. The stock has a market cap of $457.97 million, a PE ratio of -9.45 and a beta of 1.51.

Insiders Place Their Bets

In other Gevo news, CFO Oluwagbemileke Yusuf Agiri sold 73,284 shares of the firm's stock in a transaction dated Friday, December 5th. The shares were sold at an average price of $2.31, for a total value of $169,286.04. Following the completion of the sale, the chief financial officer owned 271,224 shares of the company's stock, valued at $626,527.44. This trade represents a 21.27% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Over the last 90 days, insiders have sold 83,284 shares of company stock valued at $190,186. Corporate insiders own 6.80% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Franklin Resources Inc. bought a new stake in Gevo during the 4th quarter valued at $28,000. Mackenzie Financial Corp purchased a new position in shares of Gevo during the third quarter valued at $29,000. Cibc World Markets Corp purchased a new stake in Gevo in the fourth quarter worth about $31,000. Balyasny Asset Management L.P. bought a new position in Gevo during the 4th quarter worth about $35,000. Finally, Abel Hall LLC purchased a new position in Gevo during the 4th quarter valued at about $36,000. 35.17% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have commented on GEVO. Northland Securities reiterated an "outperform" rating and set a $3.00 price objective on shares of Gevo in a research report on Wednesday, December 31st. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Gevo in a report on Thursday, January 22nd. Two investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $6.42.

View Our Latest Research Report on GEVO

Gevo Company Profile

(Get Free Report)

Gevo, Inc NASDAQ: GEVO is a renewable chemicals and biofuels company that develops and produces low-carbon alternatives to petroleum-based products. The company's core technology platform converts fermentable sugars into isobutanol, which can be further processed into sustainable aviation fuel (SAF), renewable gasoline, diesel, and jet fuel. Gevo's integrated biorefinery model combines fermentation, recovery, and downstream processing to deliver scalable, drop-in replacements for conventional fossil-derived hydrocarbons.

Gevo's primary products include isobutanol, a four-carbon alcohol used as a building block for various fuels and chemicals, and hydrocarbon fuels that meet ASTM specifications for aviation and road transport.

Featured Stories

Earnings History for Gevo (NASDAQ:GEVO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Gevo Right Now?

Before you consider Gevo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gevo wasn't on the list.

While Gevo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines